Stocks-TAK-Takeda Pharmaceutical Co Ltd

TAK Takeda Pharmaceutical Co Ltd

14.58 0.22 (1.53%)
Invest
Invest

Overview

Prev Close14.58
Day's Range 14.35 - 14.57
52 Week Range 12.25 - 15.34
Average Volume (3m)3.03M
1-Year Return7.52%
Beta0.5588
Market Cap45.33B
P/E Ratio27.19
Revenue30.17B
EPS0.5362
Dividend (Yield)0.576367 (3.95%)
1 Day 1 Week 1 Month 3 Months 6 Months 1 Year 3 Years Max
Chart times in UTC
Industry Pharmaceuticals Major
CEO Christophe Weber, PhD
Employees 47,347

FINANCIAL SUMMARY

For the fiscal year ended 31/3/2022: Takeda Pharmaceutical Co Ltd's revenues increased by 5.34% and amounted to 31.76B. Net income decreased by 42.25% to 2.05B. Net assets decreased by 0.06% to 46.83B and EPS decreased from 1.13 to 0.65.
TAK's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
53.75%
Net Profit Margin
7.31%
Operating Margin
13.41%
Return On Investment
2.80%
12/21
03/22
06/22
09/22
Total Revenue
7.93B
7.51B
7.49B
7.25B
Gross Profit
4.41B
3.57B
4.22B
4.01B